Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells

Drug Metabolism and Disposition

Volumn 27, Issue 7, 1999, Pages 798-803

  Lanza, Diane L ^a   Code, Erin ^b   Crespi, Charles L ^b   Gonzalez, Frank J ^c   Yost, Garold S ^a  

^a UNIVERSITY OF UTAH   (United States)

^b Gentest Corporation   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(N ACETYLCYSTEIN S YL)METHYL]INDOLE; 3 INDOLEMETHANOL; 3 METHYLENEINDOLENINE; 3 METHYLOXINDOLE; ACETYLCYSTEINE; CYTOCHROME P450 ISOENZYME; IMINE; INDOLE DERIVATIVE; NAPHTHALENE; RECOMBINANT PROTEIN; SKATOLE; TOXIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; ENZYME SUBSTRATE; EPOXIDATION; HUMAN; HUMAN CELL; HYDROXYLATION; LUNG TOXICITY; LYMPHOBLASTOID CELL; METABOLISM; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; EPOXY COMPOUNDS; GLUTATHIONE; HUMANS; HYDROGENATION; LYMPHOCYTES; NAPHTHALENES; RECOMBINANT PROTEINS; SKATOLE; SUBSTRATE SPECIFICITY;

EID: 0032990708     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Buckpitt AR and Bahnson LS (1986) Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41:333-341.
2. Buckpitt AR, Chang AM, Weir A, van Winkle L, Duan X, Philpot R and Plopper CG (1995) Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol Pharmacol 47:74-81.
3. Chichester CH, Buckpitt AR, Chang A and Plopper CG (1994) Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells. Mol Pharmacol 45: 664-672.
4. Crespi CL, Gonzalez FJ, Steimel DT, Turner TR, Gelboin HV, Penman BW and Langenbach R (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic cytochrome P4502D6. Carcinogenesis 12:1197-1201.
5. Crespi CL, Langenbach R and Penman BW (1993) Human cell lines, derived from AHH-1 TK± human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology 82:89-104.
6. Crespi CL, Penman BW, Steimel DT, Smith T, Yang CS and Sutter TR (1997) Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens. Carcinogenesis 12:83-89.
7. Nhamburo PT, Kimura S, Mcbride OW, Kozak CA, Gelboin H and Gonzalez FJ (1990) The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. Biochemistry 29:5491-5499.
8. Penman BW, Chen LP, Gelboin HV, Gonzalez FJ and Crespi CL (1994) Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA-substrate specificity with model substrates and promutagens. Carcinogenesis 15:1931-1937.
9. Ramakanth S, Thornton-Manning JR, Wang H, Maxwell H and Yost GS (1994) Correlation between pulmonary cytochrome P450 transcripts and the organ-selective pneumotoxicity of 3-methylindole. Toxicol Lett 71:77-85.
10. Ritter JK, Owens IS, Negishi M, Nagata K, Sheen YY, Gillette JR and Sasame HA (1991) Mouse pulmonary cytochrome P450 naphthalene hydroxylase: cDNA cloning, sequence, and expression in Saccaromyces cerevisiae. Biochemistry 30:11430-11437.
11. Ruangyuttikarn W, Appleton ML and Yost GS (1991) Metabolism of 3-methylindole in human tissues. Drug Metab Dispos 19:977-984.
12. Skiles GL and Yost GS (1996) Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole. Chem Res Toxicol 9:291-297.
13. Skordos KW, Laycock JD and Yost GS (1998b) Thioether adducts of a new imine reactive intermediate of the pneumotoxin 3-methylindole. Chem Res Toxicol 11:1326-1331.
14. Skordos KW, Skiles GL, Laycock JD, Lanza DL and Yost GS (1998a) Evidence supporting the formation of 2,3-epoxy-3-methylindoline: A reactive intermediate of the pneumotoxin 3-methylindole. Chem Res Toxicol 11:741-749.
15. Thornton-Manning JR, Appleton ML, Gonzalez FJ and Yost GS (1996) Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: Correlation of 3-methyleneindolenine formation and protein-binding. J Pharmacol Exp Ther 276:21-29.
16. Thornton-Manning JR, Ruangyuttikarn W, Gonzalez FJ and Yost GS (1991) Metabolic activation of the pneumotoxin, 3-methylindole, by vaccinia-expressed cytochrome P450s. Biochem Biophys Res Commun 181:100-107.
17. Wang H, Lanza DL and Yost GS (1998) Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch Biochem Biophys 349:329-340.
18. Yost GS (1989) Mechanisms of 3-methylindole pneumotoxicity. Chem Res Toxicol 2:273-279.
19. Yost GS (1997) Selected nontherapeutic agents, in Comprehensive Toxicology (Sipes IG, McQueen CA and Gandolfi AJ eds) vol 8 (Toxicology of the Respiratory Tract; Roth RA ed) pp 591-610, Elsevier Science, Oxford.